research
A Near-Perfect Cancer Score Lost Its Operating Point
Across nine cohorts, compact gene panels could discriminate well while locked sensitivity or specificity collapsed.
Summary
Across nine cohorts, compact gene panels could discriminate well while locked sensitivity or specificity collapsed.
The REDE preprint audited differential-expression evidence across nine public microarray cohorts spanning pancreatic, breast and lung cancers. Exact gene-list confirmation was often limited, while large effects and pathways replicated more consistently. Some compact 19-gene panels retained ROC-AUC values near one on external data yet failed at the discovery cohort's fixed decision threshold, producing zero specificity or very low sensitivity. The authors frame reproducibility as a ladder from list membership through effect, pathway, discrimination and operating-point transfer; the analysis is retrospective and does not validate a clinical diagnostic.
Why it matters
Across nine cohorts, compact gene panels could discriminate well while locked sensitivity or specificity collapsed.
Limits and context
- The authors frame reproducibility as a ladder from list membership through effect, pathway, discrimination and operating-point transfer; the analysis is retrospective and does not validate a clinical diagnostic.
Key claims
Across nine cohorts, compact gene panels could discriminate well while locked sensitivity or specificity collapsed.
Qualification: The authors frame reproducibility as a ladder from list membership through effect, pathway, discrimination and operating-point transfer; the analysis is retrospective and does not validate a clinical diagnostic.
Evidence: source-2026-08-05-006
Sources
- arXiv preprint 2608.02796arXiv · primary research
Corrections
No corrections have been recorded for this story.